» Articles » PMID: 30868001

Transfusion Transmissible Infections: Maximizing Donor Surveillance

Overview
Journal Cureus
Date 2019 Mar 15
PMID 30868001
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction The World Health Organization (WHO) recommends that all blood transfusion services must screen donated blood for human immunodeficiency virus (HIV) one and two, hepatitis B, hepatitis C and syphilis. A mandatory screening for malaria is also warranted in malaria endemic areas. Our study aimed at analyzing the prevalence and different diagnostic methods of screening transfusion transmitted infections (TTIs) in replacement and voluntary, non-remunerated donors in the blood bank of a tertiary care hospital in Islamabad, Pakistan. Methods The cross-sectional, descriptive study was conducted on 30,470 blood donors from July 2015 to October 2017, in the blood bank of a 500-bed teaching hospital in Islamabad. Initially all blood donors were screened for HIV one, HIV two, hepatitis B and hepatitis C by serological testing. The seronegative samples were further tested by nucleic acid amplification test (NAT). Malaria was screened using immuno-chromatographic antigen-detection tests, while treponema pallidum was screened by electrochemiluminescence immunoassay to detect treponema pallidum (TP) antibodies. All infected blood and blood products were discarded and donors were contacted. The donors were deferred from blood donation according to WHO guidelines. They were also counselled and referred to the infectious diseases clinic. The collected data was analyzed on IBM's statistical package for the social sciences (SPSS) version 21. Results The results revealed that amongst the 30,470 donors, 997 (3.27%) donors were found infected with one or more TTI while 29,473 (96.73%) donors were found safe. Individuals who tested positive on serology for hepatitis B were 322 (1.06%), hepatitis C were 392 (1.29%) and HIV were 49 (0.16%). The seronegative donors were tested by NAT. NAT on seronegative samples showed that 10 (0.03%) donors tested positive for hepatitis B virus deoxyribonucleic acid, while only three (0.01%) were positive for hepatitis C ribonucleic acid. No donor was found positive for HIV by NAT testing. Syphilis testing revealed a frequency of 228 (0.75%) positive results while only five (0.02%) donors were found infected with malaria. Conclusion The results testify that standardized blood component screening can save transmission of infections through blood transfusion. They also establish the superiority of NAT screening over serological tests in decreasing the residual risk of transfusion transmitted infections.

Citing Articles

HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon.

Mangala C, Takou D, Maulot-Bangola D, Beloumou G, Rebienot Pellegrin O, Sosso S PLoS One. 2024; 19(9):e0305935.

PMID: 39226273 PMC: 11371224. DOI: 10.1371/journal.pone.0305935.


Blood donation practices, processing and utilisation of blood components in government tertiary hospitals in Nigeria: a multicentre cooperative study.

Umar G, Abdulqadir I, Ugwu N, Adeyemo T, Yau N, Hassan A Int Health. 2023; 16(6):636-641.

PMID: 37956086 PMC: 11532670. DOI: 10.1093/inthealth/ihad105.


Genetic diversity of the human immunodeficiency virus of type 1 in Gabonese transfusional settings.

Mangala C, Fokam J, Maulot-Bangola D, Rebienot-Pellegrin O, Nkoa T BMC Infect Dis. 2023; 23(1):191.

PMID: 36997860 PMC: 10061732. DOI: 10.1186/s12879-023-08154-7.


Frequency of transfusion transmissible infections among blood donors of Rawalpindi District, Pakistan.

Ghazanfar S, Hassan S, Shahid Z, Khan M, Malik A, Bhutta H Afr Health Sci. 2023; 22(3):590-598.

PMID: 36910375 PMC: 9993266. DOI: 10.4314/ahs.v22i3.63.


Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan.

Ali S, Raza N, Irfan M, Mohammad M, Kazmi F, Fatima Z Cureus. 2023; 15(1):e34216.

PMID: 36852365 PMC: 9958204. DOI: 10.7759/cureus.34216.


References
1.
Busch M . Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after ten years. Dev Biol (Basel). 2007; 127:87-112. View

2.
Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M . HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors. J Clin Virol. 2007; 39(4):282-7. DOI: 10.1016/j.jcv.2007.05.001. View

3.
El Ekiaby M, Lelie N, Allain J . Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals. 2010; 38(1):59-64. DOI: 10.1016/j.biologicals.2009.10.015. View

4.
Roth W, Busch M, Schuller A, Ismay S, Cheng A, Seed C . International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang. 2011; 102(1):82-90. DOI: 10.1111/j.1423-0410.2011.01506.x. View

5.
Jain R, Aggarwal P, Gupta G . Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections. ISRN Hematol. 2012; 2012:718671. PMC: 3447329. DOI: 10.5402/2012/718671. View